ProterixBio, Inc. will be attending Precision Medicine World Conference 2018 Silicon Valley, to be held January 22-24th at the Computer History Museum, Mountain View, CA. The Precision Medicine World Conference (PMWC), formerly known as the Personalized Medicine World Conference, is an independent and established conference series considered to be the preeminent precision medicine conference that attracts recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization and collaboration.
Michael F. Miller, Ph.D., president and chief executive officer of ProterixBio, will speak at the conference. His presentation, which is titled “Molecular Assessments for Chronic Respiratory Disease” will highlight ProterixBio’s proprietary molecular assessments to improve care and accelerate therapeutics development for patients with chronic respiratory diseases. The company’s first product is focused on COPD (chronic obstructive pulmonary disease) which is a leading cause of death and contributor to health care spending worldwide.
For more information: